Two Sigma Advisers
TIL icon

Two Sigma Advisers’s Instil Bio TIL Stock Holding History

Two Sigma Advisers’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,089
Closed -$289K – 2528
2024
Q2 		$289K Sell
28,089
-1,400
-5% -$15.1K ﹤0.01% 2083
2024
Q1 		$318K Sell
29,489
-7,300
-20% -$80K ﹤0.01% 2050
2023
Q4 		$280K Sell
36,789
-325
-0.9% -$2.35K ﹤0.01% 2124
2023
Q3 		$318K Sell
37,114
-11,866
-24% -$120K ﹤0.01% 1962
2023
Q2 		$540K Sell
48,980
-7,355
-13% -$89.9K ﹤0.01% 1781
2023
Q1 		$745K Buy
56,335
+19,085
+51% +$282K ﹤0.01% 1775
2022
Q4 		$469K Buy
+37,250
New +$1.84M ﹤0.01% 1902

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Advisers's TIL Position: Q3 2024 in Review

Two Sigma Advisers sold out of Instil Bio (TIL) in Q3 2024, closing a stake of 28,089 shares — an estimated $289K sold.

Two Sigma Advisers first reported a position in TIL in Q4 2022 and held it in 7 quarters. The position peaked at $745K in Q1 2023. 49 funds tracked by Wall St. Rank hold TIL as of Q3 2024.

  • Two Sigma Advisers reported no remaining Instil Bio position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 28,089 Instil Bio shares in Q3 2024, an estimated $289K.
  • Two Sigma Advisers first reported a position in Instil Bio in Q4 2022 and held it in 7 quarters.
  • Two Sigma Advisers's Instil Bio position peaked at $745K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Instil Bio as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.